IPLCMS Hybrid Assays to Support Neurodegenerative Studies in Parkinson’s Disease
Time: 10:45 am
day: Conference Day One
Details:
- Exploring assay validation: context of use, validation package, confirmatory experiments to determine precision of assay
- Utility of assays to robustly support LRRK2-directed therapeutics
- Advantages of this technique over traditional immunoassays
